Updated Jul 16, 2026
Reed Kimberly A. has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 3.8K | $0.00 | |
| 2026-05-21 | MNTS | Momentus Inc. | M — Option exercise | 913 | $0.00 | |
| 2025-06-30 | MNTS | Momentus Inc. | A — Grant or award | 16.3K | $0.00 | |
| 2024-11-05 | MNTS | Momentus Inc. | M — Option exercise | 2.4K | $0.00 | |
| 2024-11-05 | MNTS | Momentus Inc. | M — Option exercise | 222 | $0.00 |
Reed Kimberly A. is a corporate insider — currently tracked as Director of TAKEDA PHARMACEUTICAL CO LTD (TAK). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Reed Kimberly A. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.